A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

470

Participants

Timeline

Start Date

October 26, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Locally Advanced Unresectable or Metastatic Solid Tumors
Interventions
DRUG

IBI343

IBI343 will be administered intravenously (IV) on Day 1 of every 21-day cycle.

Trial Locations (39)

2010

RECRUITING

St Vincent Hospital, Darlinghurst

2500

RECRUITING

Cancer Care Wollongong, Wollongong

4217

RECRUITING

Pindara Private Hospital, Benowa

4575

RECRUITING

Sunshine Coast University Private Hospital, Birtinya

75039

RECRUITING

NEXT Dallas, Irving

78229

RECRUITING

NEXT San Antonio, San Antonio

78758

RECRUITING

NEXT Austin, Austin

Unknown

RECRUITING

Anhui Cancer Hospital, Hefei

RECRUITING

Anhui Provincial Hospital, Hefei

RECRUITING

The First Affiliated Hospital of Wannan Medical College, Wuhu

RECRUITING

Beijing Cancer Hospital, Beijing

RECRUITING

Tumor Hospital, Chinese Academy of Medical Sciences, Beijing

RECRUITING

Fujian Cancer Hospital, Fuzhou

RECRUITING

Sun Yat-sen Memorial Hospital Sun Yat-Sen university, Guangzhou

RECRUITING

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou

RECRUITING

Henan Provincial People's Hospital, Zhengzhou

RECRUITING

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

RECRUITING

Hubei Cancer Hospital, Wuhan

RECRUITING

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technolog, Wuhan

RECRUITING

Hunan Cancer Hospital, Changsha

RECRUITING

Nanjing Drum Tower Hospital, Nanjing

RECRUITING

Jiangxi Cancer Hospital, Nanchang

RECRUITING

The Second Affiliated Hospital of Nanchang University, Nanchang

RECRUITING

The First Hospital of China Medical University, Shenyang

RECRUITING

Ningxia Medical University General Hospital, Yinchuan

RECRUITING

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

RECRUITING

Jinan Central Hospital, Jinan

RECRUITING

Shandong Cancer Hospital, Jinan

RECRUITING

Jining First People's Hospital, Jining

RECRUITING

The Affiliated Hospital of Qingdao University, Qingdao

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

RECRUITING

Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

RECRUITING

Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

RECRUITING

West China Hospital of Sichuan University, Chengdu

RECRUITING

Tianjin Cancer Hospital, Tianjin

RECRUITING

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

RECRUITING

Zhejiang Cancer Hospital, Hangzhou

RECRUITING

Zhejiang Provincial People's Hospital, Hangzhou

RECRUITING

Ningbo Medical Center Li Huili Hospital, Ningbo

All Listed Sponsors
collaborator

Fortvita Biologics (USA)Inc.

INDUSTRY

collaborator

TigerMed

INDUSTRY

lead

Innovent Biologics (Suzhou) Co. Ltd.

INDUSTRY